6505--Pluvicto, STL 36C255-25-AP-0008

Award Notice Posted

Solicitation number
36C25525N0396
Agency
Awarded
to Novartis Pharmaceuticals Corporation
Set-aside
No set-aside

Opportunity facts

Contract number
36F79720D018036C25525N0396 Federal contract award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 has awarded contract 36F79720D018036C25525N0396 to Novartis Pharmaceuticals Corporation for the procurement of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), a pharmaceutical product. The contract was awarded on August 11, 2025, with a total value of $736,610.00. This award notice represents the acquisition of a specialized medical treatment through the VA healthcare system, with Novartis serving as the contracted supplier for this radiopharmaceutical therapy.

Notice text

PLUVICTO (lutetium Lu 177 vipivotide tetraxetan). Awarded contract 36F79720D018036C25525N0396 to Novartis Pharmaceuticals Corporation for 736610.00 on 2025-08-11.

Files

File Type Posted
36F79720D0180 36C25525N0396_1.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--INTENT TO SOLE SOURCE Radiopharm - Lutathera & Pluvicto - Lebanon VAMC NAICS 325412 Veterans Integrated Service Network 4 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors